Growth Metrics

OmniAb (OABI) Depreciation & Amortization (CF) (2022 - 2026)

OmniAb (OABI) reported Depreciation & Amortization (CF) of $606000.0 for Q1 2026, down 87.22% year-over-year from $4.7 million in Q1 2025, and down 92.14% on a QoQ basis from $7.7 million in Q4 2025.

OmniAb (OABI) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $606000.0 in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 87.22% year-over-year to $606000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.6 million (down 24.64% YoY) and the FY2025 annual result came in at $21.8 million, down 7.76% from the prior year.
  • Depreciation & Amortization (CF) slipped to $606000.0 in Q1 2026 per OABI's latest filing, from $7.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $7.7 million in Q4 2025 and bottomed at $606000.0 in Q1 2026.
  • The 5-year median for Depreciation & Amortization (CF) is $4.8 million (2023), against an average of $4.9 million.
  • The widest annual swing landed in 2024, when Depreciation & Amortization (CF) surged 54.15%; it then plunged 87.22% in 2026.
  • Tracing OABI's Depreciation & Amortization (CF) over 5 years: stood at $4.8 million in 2022, then increased by 2.37% to $4.9 million in 2023, then jumped by 54.15% to $7.6 million in 2024, then gained by 1.33% to $7.7 million in 2025, then slumped by 92.14% to $606000.0 in 2026.
  • Per Business Quant, the three latest OABI Depreciation & Amortization (CF) figures stand at $606000.0 (Q1 2026), $7.7 million (Q4 2025), and $4.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 55.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 123.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 13.55 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 606,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 606,000.00
Mar 31, 2026 606,000.00
Dec 31, 2025 7.71 Mn
Dec 31, 2025 7.71 Mn
Sep 30, 2025 4.66 Mn
Sep 30, 2025 4.66 Mn
Jun 30, 2025 4.65 Mn
Jun 30, 2025 4.65 Mn
Mar 31, 2025 4.74 Mn
Mar 31, 2025 4.74 Mn
Dec 31, 2024 7.61 Mn
Dec 31, 2024 7.61 Mn
Sep 30, 2024 4.93 Mn
Sep 30, 2024 4.93 Mn
Jun 30, 2024 6.10 Mn
Jun 30, 2024 6.10 Mn
Mar 31, 2024 4.95 Mn
Mar 31, 2024 4.95 Mn
Dec 31, 2023 4.93 Mn
Dec 31, 2023 4.93 Mn
Sep 30, 2023 4.84 Mn
Sep 30, 2023 4.84 Mn
Jun 30, 2023 4.86 Mn
Jun 30, 2023 4.86 Mn
Mar 31, 2023 4.86 Mn
Mar 31, 2023 4.86 Mn
Dec 31, 2022 4.82 Mn
Dec 31, 2022 4.82 Mn
Sep 30, 2022 4.50 Mn
Sep 30, 2022 4.50 Mn
Jun 30, 2022 4.49 Mn
Jun 30, 2022 4.49 Mn
Mar 31, 2022 4.44 Mn
Mar 31, 2022 4.44 Mn